← SynDRA
EMORFAZONE
SynDRA canonical compound SYN0030119 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Mechanism of action | anti-inflammatory agent | cyclooxygenase inhibitor |
| Indication | mouth inflammation |
| Disease area | dental |
Mechanisms of action (all sources)
- anti-inflammatory agent
- cyclooxygenase inhibitor
Cross-references
Synonyms
- nandron
- pentoil
- pentoyl
- M 73101
- M73101
- Emorfazona
- Pentoil
- Emorfazonum
- 4-Ethoxy-2-methyl-5-morpholino-3(2H)-pyridazinone
- 4-Ethoxy-2-methyl-5-(4-morpholinyl)-3(2H)-pyridazinone
- V93U9DH62C
- DTXCID802981
- 4-Ethoxy-2-methyl-5-(morpholin-4-yl)pyridazin-3(2H)-one
- RefChem:590759
- Nandron
- 3(2H)-Pyridazinone, 4-ethoxy-2-methyl-5-morpholino-
- Pentoyl
- Emorfazone [INN:JAN]
- Emorfazone [INN-French]
- Emorfazonum [INN-Latin]
- Emorfazona [INN-Spanish]
- EINECS 254-220-9
- BRN 0995465
- UNII-V93U9DH62C
- 4-ethoxy-2-methyl-5-morpholin-4-ylpyridazin-3-one
- Pentoil (TN)
- EMORFAZONE [MI]
- EMORFAZONE [INN]
- EMORFAZONE [JAN]
- Emorfazone (JP17/INN)
- EMORFAZONE [WHO-DD]
- SCHEMBL26203
- orb1298343
- CHEBI:31535
- 3(2H)-Pyridazinone, 4-ethoxy-2-methyl-5-(4-morpholinyl)-
- Tox21_113708
- AKOS040759683
- NCGC00249932-01
Look up EMORFAZONE in the interactive SynDRA portal →